A Worldwide Milestone in Cell Analysis - 40 Years of Flow Cytometry
Posted on: Thursday, 18 June 2009, 08:00 CDT
GORLITZ,
Today, the German biotechnology company celebrates this anniversary at
the Saxonian State Vineyard Castle Wackerbarth near Dresden. For the festive
ceremony, CEO
In 1968, the fluorescence based cytometry was developed by Professor Dr.
Fluorescence based flow cytometry is a standard method for automated and rapid cell analysis and cell enumeration procedures. Using most modern optoelectronics, cells and particles of small size, even in nanometer range, are detected. The cells are marked with specific reagents and excited by one or more laser, consequently the emitted fluorescent signals are collected. With the obtained data, cells can be characterized, classified, quantified and sorted. For HIV monitoring, accompanying the antiretroviral therapy of AIDS patients, it is necessary to determine the number of CD4 cells.
Partec has developed a generation of robust, easy to operate and cost effective flow cytometers that can be operated in resource-poor areas in developing countries. 75 employees are working at the company site in Goerlitz, where the dedicated diagnostic solutions are being developed and manufactured. Partec offers the complete diagnostic package and reagents in the fight against Tb, Malaria and HIV/ AIDS.
http://www.partec.com Claudia Khmel Partec GmbH Am Flugplatz 13, 02828 Gorlitz Fon: +49-(0)3581-8746-0 c.khmel@partec.comSOURCE Partec GmbH
Source: PR Newswire
Related Articles
- Cryo-Cell International's Stem Cell Research and Development Helps the Fight Against Breast Cancer
- New Stem Cell Procedure is Developed
- HepaLife Surpasses Major Milestone in Cell-Based Vaccine Development for Avian Influenza
- New Studies in Patients With Sickle Cell Disease Who Develop Pulmonary Hypertension-Recruiting Now for Clinical Trials
- Cerionx and BioProcessors Partner to Improve High Throughput Cell Culture Process Development Efficiency for the BioPharma Industry
- UCI Students, Cell-Phone Game Developer Partner to Create Opportunities
- MultiCell Enters into a Joint Venture With Living Cell Technologies to Develop Adult Liver Cell Technologies for Drug Discovery, Protein Production and Therapeutic Clinical Applications
- Vitamin A Deficiency Increases the In Vivo Development of IL-10- Positive Th2 Cells and Decreases Development of Th1 Cells in Mice1,2
- Analysing the Action of Bacterial Toxins in Living Cells With Fluorescence Resonance Energy Transfer (FRET)
- Why Some Stem Cells Die in Developing Brain
 |
 |
User Comments (0)
RSS Feeds